Author: Bella Hayes
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Customers Bancorp (NYSE:) To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Customers Bancorp between March 1, 2024 and August 8, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York–(Newsfile Corp. – January 5, 2025) – Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims…
Investing.com — Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week. InvestingPro subscribers always get first dibs on market-moving AI analyst comments. Upgrade today! American Airlines What happened? On Monday, Raymond James upgraded American Airlines (NASDAQ:) to Outperform with a $24 price target. *TLDR: New Citi card deal (2026 Citi is transitioning the remainder of Barclays AAL Customer book for branded Credit Card LINK) to increase remuneration. What’s the full story? Raymond James upgraded American Airlines from Market Perform to Outperform, citing an attractive risk-reward profile and above-consensus forecasts. The analysts highlighted…
TAIPEI (Reuters) – Taiwan’s Foxconn (SS:601138), the world’s largest contract electronics maker and Apple (NASDAQ:AAPL)’s biggest iPhone assembler, reported on Sunday that its fourth-quarter revenue jumped 15.2%, reaching a record high for the quarter. Source link
New York, New York–(Newsfile Corp. – January 4, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: NASDAQ:) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Applied Therapeutics class action, go to https://rosenlegal.com/submit-form/?case_id=32500 or…
New York, New York–(Newsfile Corp. – January 4, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) pursuant and/or traceable to Kyverna’s initial public offering conducted on February 8, 2024 (the “IPO”), of the important February 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased Kyverna common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Kyverna class action, go to https://rosenlegal.com/submit-form/?case_id=32239 or call Phillip…
New York, New York–(Newsfile Corp. – January 4, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Customers Bancorp, Inc. (NYSE: NYSE:) between March 1, 2024 and August 8, 2024, both dates inclusive (the “Class Period”), of the January 31, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Customers Bancorp securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join…
New York, New York–(Newsfile Corp. – January 5, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Silvaco Group, Inc. (NASDAQ: SVCO) resulting from allegations that Silvaco may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Silvaco securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. WHAT TO DO NEXT: To…
New York, New York–(Newsfile Corp. – January 4, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) between January 19, 2024 and September 19, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Kaspi.kz securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To…
New York, New York–(Newsfile Corp. – January 4, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ: LON:) between February 23, 2022 and December 17, 2024, both dates inclusive (the “Class Period”), of the February 21, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased AstraZeneca (NASDAQ:) securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the…
New York, New York–(Newsfile Corp. – January 4, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Enphase Energy, Inc. (NASDAQ: NASDAQ:) between April 25, 2023 and October 22, 2024, both dates inclusive (the “Class Period”), of the important February 11, 2025 lead plaintiff deadline. SO WHAT: If you purchased Enphase common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Enphase Energy class action, go to…